Pioglitazone treatment prior to transplantation improves the efficacy of human mesenchymal stem cells after traumatic brain injury in rats

Traumatic brain injury is a leading cause of death and disability around the world. So far, drugs are not available to repair brain damage. Human mesenchymal stem cell (hMSC) transplantation therapy is a promising approach, although the inflammatory microenvironment of the injured brain affects the...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Mahasweta, Mayilsamy, Karthick, Tang, Xiaolan, Han, Jung Yeon, Foran, Elspeth, Willing, Alison E., Mohapatra, Shyam S., Mohapatra, Subhra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754424/
https://www.ncbi.nlm.nih.gov/pubmed/31541141
http://dx.doi.org/10.1038/s41598-019-49428-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754424/
https://www.ncbi.nlm.nih.gov/pubmed/31541141
http://dx.doi.org/10.1038/s41598-019-49428-y

Ejemplares similares